Highlights
NASDAQ: DCPH       Deciphera Pharmaceuticals Inc
Last Price Today's Change   Day's Range   Trading Volume
48.91   +0.93 (1.94%)  48.27 - 49.97  476,100

Overview

 
Avg Volume (4 weeks):558,155
4 Weeks Range:34.12 - 49.97
4 Weeks Price Volatility (%):
93.31%
52 Weeks Range:19.69 - 49.97
52 Weeks Price Volatility (%):
96.50%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Deciphera Pharmaceuticals Inc is a biotechnology company, develops and manufactures kinase-inhibiting drugs for the treatment of cancers and immunological diseases. It holds a diverse pipeline of drug candidates that includes three clinical-stage and two research-stage programs. Its lead drug candidate DCC-2618 is designed to inhibit the full spectrum of mutant or amplified KIT and Pdgfra kinases that drive cancers such as gastrointestinal stromal tumors, advanced systemic mastocytosis, gliomas, and other solid tumors. In addition it is also developing two other clinical-stage drug candidates, DCC-3014 and Rebastinib. Geographically all the operations are functioned through the region of US.

  Be the first to like this.
 


 

4308  3684  701  236 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CHK 0.70+0.01 
 EEM 43.13+0.34 
 AMD 38.56+0.21 
 SPY 311.79+2.24 
 ACB 2.73-0.56 
 AIHS 1.07+0.65 
 AMRN 24.02+2.53 
 FCEL 0.825-0.064 
 TVIX 7.12-0.71 
 UBER 26.79+0.80 
Partners & Brokers